Trials / Completed
CompletedNCT00620893
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Bp Consulting, Inc · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate and compare 2 artificial tears in their ability to reduce post LASIK dry eye signs and symptoms. The secondary endpoint of this study is to evaluate refractive regression in these patients. The 'Refractive Outcome' data point will be defined as the difference between the post-op spherical equivalent (SE) and the pre-op targeted SE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG- 400 based artificial tear | Baseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily |
| DRUG | Systane | Baseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2008-02-22
- Last updated
- 2009-09-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00620893. Inclusion in this directory is not an endorsement.